205 related articles for article (PubMed ID: 30910201)
1. High iodine intake and central lymph node metastasis risk of papillary thyroid cancer.
Zhao H; Li H; Huang T
J Trace Elem Med Biol; 2019 May; 53():16-21. PubMed ID: 30910201
[TBL] [Abstract][Full Text] [Related]
2. High Iodine Nutrition May Be a Risk Factor for Cervical Lymph Node Metastasis in Papillary Thyroid Cancer Patients.
Fan L; Tian Q; Xiu C; Wang F; Yuan Z; He Q; Guo L; Sun Q; Yang X; Miao S; Sun J; Sun D
Ann Nutr Metab; 2021; 77(2):90-99. PubMed ID: 34289482
[TBL] [Abstract][Full Text] [Related]
3. Low urinary iodine is a protective factor of central lymph node metastasis in papillary thyroid cancer: a cross-sectional study.
Zeng Z; Li K; Wang X; Ouyang S; Zhang Z; Liu Z; Sun J; Ye X; Kang W; Yu J
World J Surg Oncol; 2021 Jul; 19(1):208. PubMed ID: 34253203
[TBL] [Abstract][Full Text] [Related]
4. Iodine intake as a risk factor for BRAF mutations in papillary thyroid cancer patients from an iodine-replete area.
Kim HJ; Park HK; Byun DW; Suh K; Yoo MH; Min YK; Kim SW; Chung JH
Eur J Nutr; 2018 Mar; 57(2):809-815. PubMed ID: 28258306
[TBL] [Abstract][Full Text] [Related]
5. The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis.
Zhang X; Zhang F; Li Q; Aihaiti R; Feng C; Chen D; Zhao X; Teng W
Front Endocrinol (Lausanne); 2022; 13():1049423. PubMed ID: 36387866
[TBL] [Abstract][Full Text] [Related]
6. Association between iodine nutrition and cervical lymph node metastasis of papillary thyroid microcarcinoma.
Zhao H; Hu J; Cui L; Gong Y; Huang T
Front Endocrinol (Lausanne); 2023; 14():1164069. PubMed ID: 37720525
[TBL] [Abstract][Full Text] [Related]
7. High Urinary Iodine, Thyroid Autoantibodies, and Thyroid-Stimulating Hormone for Papillary Thyroid Cancer Risk.
Zhao H; Li H; Huang T
Biol Trace Elem Res; 2018 Aug; 184(2):317-324. PubMed ID: 29164514
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma: A meta-analysis.
Yan B; Hou Y; Chen D; He J; Jiang Y
Int J Surg; 2018 Nov; 59():90-98. PubMed ID: 30342280
[TBL] [Abstract][Full Text] [Related]
9. Significance of distance between tumor and thyroid capsule as an indicator for central lymph node metastasis in clinically node negative papillary thyroid carcinoma patients.
Seong CY; Chai YJ; Lee SM; Kim SJ; Choi JY; Lee KE; Hwang KT; Park SW; Yi KH
PLoS One; 2018; 13(7):e0200166. PubMed ID: 30016353
[TBL] [Abstract][Full Text] [Related]
10. [Risk factors for central neck lymph node metastases of papillary thyroid carcinoma].
Sun YS; Lyu HJ; Zhao YR; Zhang SS; Bai YX; Shi BY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):421-425. PubMed ID: 28635213
[No Abstract] [Full Text] [Related]
11. Predicting cervical lymph node metastasis in patients with papillary thyroid cancer (PTC) - Why contrast-enhanced ultrasound (CEUS) was performed before thyroidectomy.
Zhan J; Diao X; Chen Y; Wang W; Ding H
Clin Hemorheol Microcirc; 2019; 72(1):61-73. PubMed ID: 30452407
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Central Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.
Sun W; Lan X; Zhang H; Dong W; Wang Z; He L; Zhang T; Liu S
PLoS One; 2015; 10(10):e0139021. PubMed ID: 26431346
[TBL] [Abstract][Full Text] [Related]
13. Analyze and compare the predictors of ipsilateral central lymph node metastasis in papillary thyroid carcinoma with cT1a and cT1b stage.
Zhou B; Wei L; Qin J
Asian J Surg; 2021 Nov; 44(11):1357-1362. PubMed ID: 33715963
[TBL] [Abstract][Full Text] [Related]
14. Nodal status of central lymph nodes as a negative prognostic factor for papillary thyroid carcinoma.
Lee YS; Lim YS; Lee JC; Wang SG; Kim IJ; Son SM; Shin DH; Lee BJ
J Surg Oncol; 2013 Jun; 107(7):777-82. PubMed ID: 23640873
[TBL] [Abstract][Full Text] [Related]
15. The synergic effect of BRAF
Qu HJ; Qu XY; Hu Z; Lin Y; Wang JR; Zheng CF; Tan Z
Endocr J; 2018 Jan; 65(1):113-120. PubMed ID: 29070763
[TBL] [Abstract][Full Text] [Related]
16. Clinical Study of Ultrasonographic Risk Factors for Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.
Guang Y; He W; Zhang W; Zhang H; Zhang Y; Wan F
Front Endocrinol (Lausanne); 2021; 12():791970. PubMed ID: 34917039
[TBL] [Abstract][Full Text] [Related]
17. Association between Iodine Intake, Thyroid Function, and Papillary Thyroid Cancer: A Case-Control Study.
Kim K; Cho SW; Park YJ; Lee KE; Lee DW; Park SK
Endocrinol Metab (Seoul); 2021 Aug; 36(4):790-799. PubMed ID: 34376043
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for central lymph node metastasis in the cervical region in papillary thyroid carcinoma: a retrospective study.
Li X; Zhang H; Zhou Y; Cheng R
World J Surg Oncol; 2021 Apr; 19(1):138. PubMed ID: 33941214
[TBL] [Abstract][Full Text] [Related]
19. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].
Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720
[TBL] [Abstract][Full Text] [Related]
20. Risk factors of central lymph node metastasis in papillary thyroid carcinoma: A retrospective cohort study.
Tang T; Li J; Zheng L; Zhang L; Shi J
Int J Surg; 2018 Jun; 54(Pt A):129-132. PubMed ID: 29723673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]